3SBioSTU:83B +7.34%89 OCF Yield % is 23.53 as of Jul. 03, 2026, which is 188% above its 10-year median of 8.17. GuruFocus rates STU:83B with a GF Score™ of 89/100 and a GF Value™ of €1.53 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 1,415 Biotechnology companies, 3SBio ranks better than 98.8% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
3SBio OCF Yield % Related Terms
3SBio OCF Yield % Historical Data
* Premium members only.
The historical data trend for 3SBio's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:83B vs VRTX, REGN, ALNY: OCF Yield % Comparison
For the Biotechnology subindustry, 3SBio's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
3SBio OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 3SBio's OCF Yield % distribution charts can be found below:
* The bar in red indicates where 3SBio's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
3SBio (STU:83B) has a OCF Yield % of 23.53 as of Jul. 03, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on 3SBio and its competitors. This is 188% above median its historical median of 8.17. Over the past decade, 3SBio's OCF Yield % has ranged from 2.17 to 27.63. According to the industry distribution chart, 3SBio ranks #17 out of 1415 companies in the Biotechnology industry, placing it in the top 1.2%.
Is 3SBio's OCF Yield % too high?
3SBio's current OCF Yield % of 23.53 is 188% above median its 10-year median of 8.17. Over the past 10 years, this metric has ranged from a low of 2.17 to a high of 27.63. Based on the distribution chart, 3SBio ranks #17 out of 1415 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, 3SBio has a GF Score™ of 89/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 3SBio's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, 3SBio ranks #17 out of 1415 companies for OCF Yield %. This places 3SBio in the top 1% of its industry — outperforming the majority of peers. Historically, 3SBio's own OCF Yield % has ranged from 2.17 to 27.63 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on 3SBio and its competitors. 3SBio's current OCF Yield % is 23.53, which is 188% above median its own 10-year median of 8.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3SBio stock overvalued right now?
Based on GuruFocus' analysis, 3SBio (STU:83B) is currently considered Modestly Overvalued. The stock's GF Value™ is €1.53, compared to a current price of €1.97 — trading 28.6% above its estimated fair value. The current OCF Yield % is 23.53, which is 188% above median its 10-year median of 8.17. 3SBio's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For 3SBio (STU:83B), the current OCF Yield % is 23.53 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 3SBio (STU:83B) Overvalued in 2026?
Based on GuruFocus' analysis, 3SBio stock appears to be overvalued.
The current stock price of €1.97 is trading 28.6% above its estimated GF Value™ of €1.53.
GuruFocus considers 3SBio to be Modestly Overvalued.
Key valuation signals for STU:83B:
OCF Yield %: 23.53 (188% above median its 10-year median of 8.17)
GF Value™: €1.53 vs. price of €1.97 (28.6% above fair value)
No single metric tells the full story. See the STU:83B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
3SBio Inc is an investment holding company. It is a primary biotechnology company. The company is principally engaged in the development, production, marketing and sale of biopharmaceutical products in the People's Republic of China. The group has only one operating segment. It has presence in Chinese mainland, USA, Other countries/regions. The majority of revenue comes from USA. The core commercialized products of the group include several bio-pharmaceutical drugs, namely, TPIAO, recombinant human erythropoietin (rhEPO) products EPIAO and SEPO, Yisaipu and Cipterbin, and a small molecule drug, Mandi series of minoxidil drugs.
89GF Score
Get the complete analysis for STU:83B
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:83B has been successfully added to your 
